Dallah Health shares approach key resistance
The article discusses the performance of Dallah Healthcare Services Company's stock, "Dallah Healthcare," during 2026. The stock experienced sharp declines in February but gradually recovered, regaining a support level at 108.70 SAR and currently testing a key resistance level at 119.00 SAR. Chances for further rebound are expected to continue if the stock maintains trading above the designated support and resistance levels, with targeted price ranges between 114.90 SAR and 122 SAR. However, there is a warning of potential decline if the support at 108.60 SAR is lost.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)